Legend CEO Ying Huang resigns; Carvykti chief named interim leader

Ying Huang at the Financial Times' Global Pharma and Biotech Summit in 2025 (courtesy Financial Times) July 27, 2026 09:38 AM EDT People Leg­end CEO Ying Huang re­signs; Carvyk­ti chief named in­ter­im leader Max Gelman Senior Editor Leg­end Biotech, the de­vel­op­er of the block­buster can­cer ther­a­py Carvyk­ti, is in the mar­ket for a new CEO. Ying Huang stepped down Fri­day af­ter serv­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER